Clene (FRA:84C0) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 26, 2026)


FRA:84C0 Clene Inc FRA:84C0
27 GF Score
Price €4.84
GF Value €0.74
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Clene Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Clene's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

FRA:84C0 vs BHST, GWLL, FTLF: Margin of Safety % (DCF Earnings Based) Comparison

For the Packaged Foods subindustry, Clene's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clene Margin of Safety % (DCF Earnings Based) vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Clene's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Clene's Margin of Safety % (DCF Earnings Based) falls into.


FRA:84C0
27GF Score
Clene Inc FRA:84C0
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Clene (FRA:84C0) Overvalued in 2026?

Based on GuruFocus' analysis, Clene stock appears to be overvalued. The current stock price of €4.84 is trading 554.1% above its estimated GF Value™ of €0.74. GuruFocus considers Clene to be Significantly Overvalued.

Key valuation signals for FRA:84C0:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: €0.74 vs. price of €4.84 (554.1% above fair value)
  • GF Score™: 27/100 with 9 warning signs

No single metric tells the full story. See the FRA:84C0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clene Business Description

Other Exchanges CLNN:USA
Address 6550 South Millrock Drive, Suite G50, Salt Lake City, UT, USA, 84121
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
27GF Score

Get the complete analysis for FRA:84C0

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.84
Price
€0.74
GF Value